Entrepreneur Briefs

Perestroika Comes None Too Soon Mikhail Gorbachev’s push to improve health care in the Soviet Union has led the Soviets to the doorstep of a small firm in Falmouth, Mass. Called Associates on Cape Cod, the venture was founded in 1974 by Woods Hole Oceanographic Institution microbiologist Stanley Watson and pioneered the commercial use of a substance derived from the blood of horseshoe crabs—limulus amebocyte lysate (LAL)—to test for pyrogens in drugs. The new procedure was c

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Mikhail Gorbachev’s push to improve health care in the Soviet Union has led the Soviets to the doorstep of a small firm in Falmouth, Mass. Called Associates on Cape Cod, the venture was founded in 1974 by Woods Hole Oceanographic Institution microbiologist Stanley Watson and pioneered the commercial use of a substance derived from the blood of horseshoe crabs—limulus amebocyte lysate (LAL)—to test for pyrogens in drugs. The new procedure was cheaper and faster than the traditional rabbit test, but the Soviets had yet to pull even rabbits out of their hats.

On a visit to the USSR last year, Thomas Novitsky, vice president and director of research for Associates on Cape Cod, asked the Soviets how many rabbit tests they currently conducted. None, they replied. Incredulous, Novitsky asked what they did instead. He claims to have been told that new batches of drugs are given to elderly patients in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies